Skip to content
Putting patients first: Retail pharmacies—and the patients they serve—are being endangered by PBM Power
This is the fourth in a series of Bio.News articles looking at the need for pharmacy benefit manager reform through the lens of the […]
Putting patients first: Separating PBM compensation from prices Is critical in reducing patient financial burden
This is the third in a series of Bio.News articles looking at the need for pharmacy benefit manager reform through the lens of the
Putting patients first: Unchecked step therapy puts PBM profits ahead of patient care
This is the second in a series of Bio.News articles looking at the need for pharmacy benefit manager reform through the lens of the
Putting patients first: Unchecked step therapy puts PBM profits ahead of patient care Read More »
Putting patients first: Why PBM reform must ensure that middlemen pass along 100% of rebates
This is the first in a series of Bio.News articles looking at the need for pharmacy benefit manager (PBM) reform through the lens of
CMS must address Part D plan abuse of IRA provisions designed to protect patient access
The Biotechnology Innovation Organization (BIO) has once again requested that the Centers for Medicare & Medicaid Services (CMS) take steps to protect patient access,
CMS must address Part D plan abuse of IRA provisions designed to protect patient access Read More »
Open enrollment can be a ‘House of Horrors’: 4 monsters for patients to beware
October is the scariest time of year. Young goblins walk the streets demanding treats, local haunted houses are packed full of fright-chasing teens, and
Open enrollment can be a ‘House of Horrors’: 4 monsters for patients to beware Read More »
Skyrocketing 340B program spending must prompt more hospital accountability
The 340B program grew by 24% in 2023, according to new figures from the government’s Health Resources and Services Administration. Sales at discounted prices
Skyrocketing 340B program spending must prompt more hospital accountability Read More »
Development of non-opioid pain medicines threated by IRA’s ‘pill penalty’
The search for safer, effective replacements for opioids is a critical public health priority, but that effort is being undermined by the Inflation Reduction
Development of non-opioid pain medicines threated by IRA’s ‘pill penalty’ Read More »
As Medicare open enrollment nears, seniors will face difficult choices despite CMS’ rosy assessment
Prescription drug coverage in Medicare will see sweeping changes – for both health plans and for the millions of American seniors they serve –
As Medicare open enrollment nears, ‘M3P’ and the out-of-pocket cap loom large
Medicare beneficiaries will soon need to begin thinking about their coverage for 2025, with the open enrollment period opening on Oct. 15. The next
As Medicare open enrollment nears, ‘M3P’ and the out-of-pocket cap loom large Read More »